JPH03500886A - アミノ酸およびヒドロキシジカルボン酸を含有するレニン抑制ペプチド類 - Google Patents

アミノ酸およびヒドロキシジカルボン酸を含有するレニン抑制ペプチド類

Info

Publication number
JPH03500886A
JPH03500886A JP1500117A JP50011789A JPH03500886A JP H03500886 A JPH03500886 A JP H03500886A JP 1500117 A JP1500117 A JP 1500117A JP 50011789 A JP50011789 A JP 50011789A JP H03500886 A JPH03500886 A JP H03500886A
Authority
JP
Japan
Prior art keywords
amino
succinyl
isopropyl
hydroxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1500117A
Other languages
English (en)
Japanese (ja)
Inventor
タイスリボングス，スビット
Original Assignee
ジ・アップジョン・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジ・アップジョン・カンパニー filed Critical ジ・アップジョン・カンパニー
Publication of JPH03500886A publication Critical patent/JPH03500886A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP1500117A 1987-11-16 1988-10-11 アミノ酸およびヒドロキシジカルボン酸を含有するレニン抑制ペプチド類 Pending JPH03500886A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US121,270 1980-02-13
US12127087A 1987-11-16 1987-11-16

Publications (1)

Publication Number Publication Date
JPH03500886A true JPH03500886A (ja) 1991-02-28

Family

ID=22395600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1500117A Pending JPH03500886A (ja) 1987-11-16 1988-10-11 アミノ酸およびヒドロキシジカルボン酸を含有するレニン抑制ペプチド類

Country Status (5)

Country Link
EP (1) EP0394311A1 (da)
JP (1) JPH03500886A (da)
DK (1) DK119590A (da)
FI (1) FI902422A0 (da)
WO (1) WO1989004833A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941235A1 (de) * 1989-12-14 1991-06-20 Bayer Ag Neue peptide, ihre herstellung und ihre verwendung in arzneimitteln
CA2191924A1 (en) * 1995-12-05 1997-06-06 Kevin Felsenstein 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
US5703129A (en) * 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
US6486193B2 (en) 1998-12-31 2002-11-26 Aventis Pharmaceuticals Inc. 3-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases
AU2003230392A1 (en) * 2002-05-17 2003-12-12 Merck And Co., Inc. Beta-secretase inhibitors
CA2512111A1 (en) 2003-01-07 2004-07-29 Merck And Co., Inc. Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
CA2529994A1 (en) 2003-06-30 2005-01-20 Merck & Co., Inc. N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
US7348448B2 (en) 2003-07-01 2008-03-25 Merck & Co., Inc. Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
AU2004277981B2 (en) 2003-10-03 2009-10-01 Merck & Co., Inc. Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
CN116096714A (zh) 2020-06-10 2023-05-09 安力高医药股份有限公司 用于治疗冠状病毒、小核糖核酸病毒和诺罗病毒感染的抗病毒化合物
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors
DE3601248A1 (de) * 1986-01-17 1987-07-23 Hoechst Ag Substituierte 4-amino-3-hydroxybuttersaeure-derivate, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
DE3610593A1 (de) * 1986-03-29 1987-10-01 Hoechst Ag Substituierte 4-amino-3-hydroxybuttersaeure-derivate verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
NZ220173A (en) * 1986-05-09 1990-01-29 Dainippon Pharmaceutical Co Tripeptide derivatives as antihypertensive agents;processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
WO1989004833A1 (en) 1989-06-01
DK119590D0 (da) 1990-05-14
DK119590A (da) 1990-05-14
EP0394311A1 (en) 1990-10-31
FI902422A0 (fi) 1990-05-15
AU2806789A (en) 1989-06-14

Similar Documents

Publication Publication Date Title
US5132400A (en) Peptides containing a (1-amino-2-hydroxy-2-heterocyclic)ethyl moiety
JPH06500561A (ja) 遷移状態模擬体としてのアミノポリオール含有ペプチド
JPH03500886A (ja) アミノ酸およびヒドロキシジカルボン酸を含有するレニン抑制ペプチド類
US4812442A (en) Tripeptide renin inhibitors
JPH02500025A (ja) 新規なｃ末端基を有するレニン抑制ペプチド
CA1309555C (en) Inhibiting peptides having a dihydroxyethylene isostere transitionstate insert
EP0483271B1 (en) Peptides containing diamino-glycols as transition-state mimics
US4839357A (en) Renin inhibitors containing phenylalanyl-histidine replacements
WO1987005302A1 (en) Novel renin-inhibiting peptides having a dihydroxyethylene isostere transition state insert
US5001113A (en) Di- or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA
JPH03504127A (ja) 置換されたフェノキシアセチル基を含有するペプチド類
US5049548A (en) Renin-inhibitory di-, tri-, and tetrapeptides
JPH04504716A (ja) 新規な極性ｎ―末端基を有するペプチド類
US4864017A (en) Novel renin inhibiting peptides having a dihyroxyethylene isostere transition state insert
EP0278158A2 (en) Renin inhibitors containing phenylalanyl-histidine replacements
JPH02504509A (ja) 非ペプチド結合を有するレニン抑制ペプチド
JPH04500202A (ja) スレプタン酸またはその誘導体類を含有するレニン抑制ペプチド類
JPS63146850A (ja) フエニルアラニル−ヒスチジン代用成分を有するレニン阻害剤
US5006511A (en) Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa
AU617740C (en) Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids
AU617740B2 (en) Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids
US5039664A (en) Renin inhibitors containing phenylalanyl-histidine replacements
JPS6110597A (ja) ペプチドアイソスタ−を含有するｃ−末端アミド環状レニン阻害剤
JPH02502457A (ja) シクロプロピル含有レニン抑制ペプチド
US5037807A (en) Renin inhibitors containing phenylalanyl-histidine replacements